|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 1996;61:183
© 1996 The Society of Thoracic Surgeons
Department of Thoracic Surgery Beth Israel Medical Center First Ave at 16th St New York, NY 10008
| The first 20% of the full text of this article appears below. |
See also page 177.
In recent years MAb identification of cancer cells has been used to enhance the recognition of smaller numbers of cancer cells in thoracic lymph nodes and in bone marrow samples. The identification of these so-called micrometastases (m) appears to be an improvement to our TNM system when using standard pathologic methods.
Passlick and associates used Ber-Ep4 as a monoclonal antibody technique to supplement the pathologic study of 125 NSCLC patients, 565 thoracic lymph nodes removed, and 91 marrow samples from either rib or iliac crest. By conventional pathologic study they found 70 had N0 disease, 25 N1, and 30 N2. With MAb pathologic study, 70 N0 became 59 N0 (3 were N1,
Related Article
Ann. Thorac. Surg. 1996 61: 177-182.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |